Actively Recruiting
Clinical Decision Tree Analysis of Hemodialysis Arteriovenous Access Choices and Creations - a Multiple-center Retrospective Cohort Study
Led by National Taiwan University Hospital · Updated on 2025-06-19
600
Participants Needed
1
Research Sites
93 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Our study aim was to utilize a decision tree analysis (DTA) model to gain insight into the decision-making process within a multiple-center cohort.
CONDITIONS
Official Title
Clinical Decision Tree Analysis of Hemodialysis Arteriovenous Access Choices and Creations - a Multiple-center Retrospective Cohort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients between the ages of 18 and 80 referred for primary hemodialysis arteriovenous access creation
- Patients in pre-kidney replacement therapy stage
- Patients in early end-stage kidney disease who urgently started hemodialysis without sufficient time to plan AV access
You will not qualify if you...
- Patients who underwent secondary arteriovenous access surgery such as transposed radiobasilic AVF or revision of arteriovenous graft
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
C
Chih-Yang Chan, phd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here